- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07349030
Fall Risk Intervention for Stroke (FRISKI)
February 25, 2026 updated by: Prudence Plummer, MGH Institute of Health Professions
Data-driven Intervention to Reduce Pre-discharge Fall Risk After Stroke
After stroke, falling is a common problem.
Falls can lead to injury, as well as fear of future falls.
It is important to try to prevent falls from happening after stroke.
To goal of this study is to test a new treatment to try to prevent falls after stroke.
The people in the study will be patients who are in the hospital receiving care after a stroke.
While they are in the hospital, the investigators will provide extra treatment that focuses on helping them not to fall.
The investigators will also teach the patients to understand risks for falls and how to avoid them.
When they leave the hospital, participants will be sent a text message every day to ask if they have had any falls.
The goal is to see if patients who received the extra therapy have fewer falls than patients who did not receive the therapy and education to help avoid falls.
If the extra treatment in the hospital can help stop people from falling after they leave the hospital, this will have a positive impact on their lives.
By not falling, they will avoid the risk of injury and having to go back to the hospital.
This project will help the investigators know how to help people with stroke live longer, healthier lives.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
Falls are one of the most significant problems for stroke survivors, often resulting in injury, fracture, rehospitalization, recurrent falls, fear of falling, avoidance of physical activity, and subsequent restricted social participation.
The rate of falls among stroke survivors is exceptionally high, especially in the first 1-3 months after discharge home from the hospital.
The high rate of early post-stroke falls occurs despite intensive inpatient rehabilitation and ongoing rehabilitation after hospital discharge.
The central hypothesis to be tested in this study is that a personalized fall prevention intervention provided during inpatient rehabilitation will reduce fall risk before discharge compared to the control intervention (usual care plus dose-matched placebo activity) and reduce the 30-day and 90-day post-discharge fall rates.
The study will examine whether a targeted fall prevention intervention delivered during inpatient rehabilitation, in addition to usual care, can reduce fall risk classified by the clinical standard, Berg Balance Scale, at the time of discharge, more than usual care with dose-matched placebo activity (Aim 1).
Upon admission to inpatient rehabilitation for stroke, patients without a prior history of falls who test positive for high fall risk using a validated, concise, bedside fall-risk assessment will be randomized 1:1 to experimental and control groups.
The investigators will compare differences between groups in the proportion that test positive for fall risk at discharge and the proportion who are discharged to a skilled nursing facility instead of home.
Following hospital discharge, falls will be tracked via a daily text message survey for 90 days.
The investigators will compare the 30-day and 90-day fall rates between the experimental and control groups (Aim 2).
There is a critical need to improve rehabilitation practices for fall prevention early after stroke within current length-of-stay constraints.
This study will determine whether an intensive, data-driven fall prevention intervention during inpatient rehabilitation can improve early post-stroke mobility and fall-related outcomes.
Study Type
Interventional
Enrollment (Estimated)
134
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Prudence Plummer, PhD
- Phone Number: 617-724-3103
- Email: pplummer@mghihp.edu
Study Contact Backup
- Name: Meaghan Costello, DPT
- Email: mcostello4@mgb.org
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02129
- Spaulding Rehabilitation Hospital
-
Contact:
- Megan Schliep, PhD
- Phone Number: 507-259-1433
- Email: mschliep@mghihp.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Inpatient rehabilitation admission for diagnosis of stroke
- Test positive for fall risk at admission (step-test and obstacle-test, "STOB", >/= 3 out of 8)
- No pre-stroke history of falls
- Community dwelling and independent in basic and instrumental activities of daily living prior to stroke
- Able to follow 1-step verbal command and demonstrate comprehension and decision-making capacity to consent to study participation
- Able to stand upright for 10 seconds with assistance of no more than one person
Exclusion Criteria:
- Brain hemorrhage due to trauma
- Prior stroke with residual physical or cognitive impairment
- Use of assistive device for ambulation prior to stroke
- Diagnosed with dementia
- Receptive or global aphasia
- Receiving chemotherapy in last 6 months or any cancer diagnosis with brain metastases
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Fall Prevention Rehabilitation
In addition to usual care, participants randomized to the experimental intervention will receive 30-minute sessions of rehabilitation 6 times a week during the first week and 3 times a week thereafter until discharge.
The intervention will target fall risk factors that are specific to the individual's fall risk profile at hospital admission.
Patient and family education on fall prevention is also included.
|
The fall prevention rehabilitation program will be provided by a licensed physical therapist and will target modifiable fall risk factors known to be associated with future fall risk after inpatient rehabilitation for stroke.
The intervention will be personalized to the individual's fall risk profile at admission.
Participants will be educated about physical, cognitive/attentional, and environmental factors associated with falls.
|
|
Active Comparator: Dose-controlled Active Control
In addition to usual care, participants randomized to the control intervention will receive 30-minute sessions of active control rehabilitation 6 times a week during the first week and 3 times a week thereafter until discharge.
The intervention will be skilled rehabilitation that does not target known fall risk factors.
Education on stroke recovery and stroke prevention will be provided as part of the control intervention.
|
The control intervention will not include any of the key ingredients in the experimental intervention.
The activities will not target known modifiable factors for fall risk, but the treatment will be a skilled therapy by a licensed provider, matching the dose of the experimental intervention.
Participants in the control group will receive education about stroke, stroke recovery, stroke prevention, wellness, and community support groups.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Berg Balance Scale
Time Frame: Immediately post intervention
|
Proportion of participants in each group who are at fall risk at hospital discharge, determined by the Berg Balance Scale (where fall risk is indicated by a score </= 43 out of 56).
|
Immediately post intervention
|
|
Fall Rate
Time Frame: 30-days post intervention
|
Prevalence of fallers (one or more falls) in each group 30 days after discharge
|
30-days post intervention
|
|
Fall Rate
Time Frame: 90 days post intervention
|
Prevalence of fallers (one or more falls) in each group 90 days after discharge
|
90 days post intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Functional Gait Assessment
Time Frame: Immediately post intervention
|
Proportion of participants in each group who are at fall risk at discharge, determined by the Functional Gait Assessment (where fall risk is indicated by a score </= 13 out of 30).
|
Immediately post intervention
|
|
Step-Obstacle Test
Time Frame: Immediately post intervention
|
Proportion of participants in each group who are at fall risk at discharge, determined by the Step-Obstacle test combination (where fall risk is indicated by a score >/= 3 out of 8).
|
Immediately post intervention
|
|
Discharge Disposition
Time Frame: Immediately post intervention
|
Location discharged to from rehabilitation hospital
|
Immediately post intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Prudence Plummer, PhD, MGH Institute of Health Professions
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
April 1, 2026
Primary Completion (Estimated)
October 31, 2027
Study Completion (Estimated)
December 31, 2027
Study Registration Dates
First Submitted
December 29, 2025
First Submitted That Met QC Criteria
January 10, 2026
First Posted (Actual)
January 16, 2026
Study Record Updates
Last Update Posted (Actual)
February 27, 2026
Last Update Submitted That Met QC Criteria
February 25, 2026
Last Verified
February 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Neurologic Manifestations
- Cerebrovascular Disorders
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Vascular Diseases
- Cardiovascular Diseases
- Mental Disorders
- Neurobehavioral Manifestations
- Neurodevelopmental Disorders
- Pathological Conditions, Signs and Symptoms
- Signs and Symptoms
- Stroke
- Communication Disorders
Other Study ID Numbers
- 26AIREA1576341
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
Clinical Trials on Fall Prevention Intervention
-
University of ValenciaUnknownAging ProblemsSpain
-
University of PennsylvaniaNational Institute on Aging (NIA)Recruiting
-
The First Hospital of Hebei Medical UniversityCompleted
-
Betul Esra CevikCompletedAccidental Fall | Fall Prevention | Fall Risk FactorsTurkey (Türkiye)
-
Sigma Theta Tau InternationalRecruiting
-
New York UniversityCompleted
-
New York UniversityCompletedHealthy Aging | Accidental Fall | Injury PreventionUnited States
-
Blue Marble Rehab IncNational Institute on Aging (NIA); Partners In Care FoundationCompleted
-
Fooyin UniversityCompleted
-
University of Colorado, DenverNational Institute on Aging (NIA)Not yet recruitingAlzheimer's Disease and Related Dementia